These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25124119)

  • 21. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial.
    Wells A; Colbear JS
    J Clin Psychol; 2012 Apr; 68(4):373-81. PubMed ID: 24469928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of group metacognitive therapy versus behavioural activation in moderately depressed students.
    Zemestani M; Davoodi I; Honarmand MM; Zargar Y; Ottaviani C
    J Ment Health; 2016 Dec; 25(6):479-485. PubMed ID: 26439473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review.
    Normann N; van Emmerik AA; Morina N
    Depress Anxiety; 2014 May; 31(5):402-11. PubMed ID: 24756930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive Behavioral Social Rhythm Group Therapy for Veterans with posttraumatic stress disorder, depression, and sleep disturbance: Results from an open trial.
    Haynes PL; Kelly M; Warner L; Quan SF; Krakow B; Bootzin RR
    J Affect Disord; 2016 Mar; 192():234-43. PubMed ID: 26748739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity: An open trial in a cohort of primary care patients.
    Kristjánsdóttir H; Salkovskis PM; Sigurdsson BH; Sigurdsson E; Agnarsdóttir A; Sigurdsson JF
    Nord J Psychiatry; 2016; 70(3):215-23. PubMed ID: 26403998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: a feasibility study.
    Morrison AP; Pyle M; Chapman N; French P; Parker SK; Wells A
    J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):280-4. PubMed ID: 24440585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open trial of group metacognitive therapy for obsessive-compulsive disorder.
    Rees CS; van Koesveld KE
    J Behav Ther Exp Psychiatry; 2008 Dec; 39(4):451-8. PubMed ID: 18295186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of group cognitive behavioral therapy compared to a discussion group for co-morbid anxiety and depression in older adults.
    Wuthrich VM; Rapee RM; Kangas M; Perini S
    Psychol Med; 2016 Mar; 46(4):785-95. PubMed ID: 26498268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metacognitive therapy in recurrent depression: a case replication series in Denmark.
    Callesen P; Jensen AB; Wells A
    Scand J Psychol; 2014 Feb; 55(1):60-4. PubMed ID: 24256292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of cognitive behaviour therapy for treatment-resistant depression with psychiatric comorbidity: comparison of individual versus group CBT in an interdisciplinary rehabilitation setting.
    Hauksson P; Ingibergsdóttir S; Gunnarsdóttir T; Jónsdóttir IH
    Nord J Psychiatry; 2017 Aug; 71(6):465-472. PubMed ID: 28598705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Ochoa S; López-Carrilero R; Barrigón ML; Pousa E; Barajas A; Lorente-Rovira E; González-Higueras F; Grasa E; Ruiz-Delgado I; Cid J; Birulés I; Esteban-Pinos I; Casañas R; Luengo A; Torres-Hernández P; Corripio I; Montes-Gámez M; Beltran M; De Apraiz A; Domínguez-Sánchez L; Sánchez E; Llacer B; Pélaez T; Bogas JL; Moritz S;
    Psychol Med; 2017 Jul; 47(9):1573-1584. PubMed ID: 28166848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study.
    Winter L; Schweiger U; Kahl KG
    BMC Psychiatry; 2020 Nov; 20(1):566. PubMed ID: 33243217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative cognitive beliefs, positive metacognitive beliefs, and rumination as mediators of metacognitive training for depression in older adults (MCT-Silver).
    Schneider BC; Veckenstedt R; Karamatskos E; Pinho LG; Morgado B; Fonseca C; Moritz S; Jelinek L
    Front Psychol; 2023; 14():1153377. PubMed ID: 37034960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder.
    van der Heiden C; Muris P; van der Molen HT
    Behav Res Ther; 2012 Feb; 50(2):100-9. PubMed ID: 22222208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of group metacognitive therapy for children (MCT-c) with generalized anxiety disorder: An open trial.
    Esbjørn BH; Normann N; Christiansen BM; Reinholdt-Dunne ML
    J Anxiety Disord; 2018 Jan; 53():16-21. PubMed ID: 29145078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of metacognitive training for depression as add-on intervention for patients with depression in acute intensive psychiatric inpatient care: A randomized controlled trial.
    Hauschildt M; Arlt S; Moritz S; Yassari AH; Jelinek L
    Clin Psychol Psychother; 2022 Sep; 29(5):1542-1555. PubMed ID: 35274407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rumination-focused cognitive behaviour therapy vs. cognitive behaviour therapy for depression: study protocol for a randomised controlled superiority trial.
    Hvenegaard M; Watkins ER; Poulsen S; Rosenberg NK; Gondan M; Grafton B; Austin SF; Howard H; Moeller SB
    Trials; 2015 Aug; 16():344. PubMed ID: 26260780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
    Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
    Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders.
    Lam KC; Ho CP; Wa JC; Chan SM; Yam KK; Yeung OS; Wong WC; Balzan RP
    Behav Res Ther; 2015 Jan; 64():38-42. PubMed ID: 25513971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.